| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 6, 2026 | ±7.1% | -5.1% | over-priced |
| February 4, 2026 | ±10.0% | +7.0% | over-priced |
| November 5, 2025 | ±7.6% | +23.6% | under-priced |
| May 7, 2025 | ±5.6% | +2.8% | over-priced |
| November 8, 2024 | ±4.3% | +13.9% | under-priced |
| May 7, 2024 | ±3.9% | -6.1% | under-priced |
| February 8, 2024 | ±4.5% | -22.4% | under-priced |
| November 8, 2023 | ±3.7% | +2.0% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.50 | $808M | $144M |
| Q2 FY2026 | $0.89 | $666M | $78M |
| Q1 FY2026 | $0.05 | $534M | $4M |
| Q4 FY2025 | $3.09 | $481M | $213M |
Lumentum Holdings Inc. Common Stock (LITE) reports in 98 days, with the next report estimated for September 19, 2026. Across the last 8 reports, options priced an average ±5.8% earnings move while the stock actually moved 10.4% on average — the market has been roughly fair on LITE's earnings risk. Fundamentals into the print: EPS up 334.4% year-over-year, revenue up 90.1%. QuantLogix's live 5-factor engine currently reads LITE as a buy at 67/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →